Table 3 Lymphoma subtypes in CNB group and surgical group
Subtypes | Number of CNB group cases | Number of surgical group cases |
|---|---|---|
NHL | 108 (98.2%) | 94 (98.9%) |
Diffuse large B cell lymphoma | 85 (78.7%) | 63 (67.0%) |
Anaplastic large cell lymphoma | 7 (6.5%) | 3 (3.2%) |
Mantle cell lymphoma | 3 (2.8%) | 8 (8.5%) |
Follicular lymphoma | 2 (1.9%) | 5 (5.3%) |
Small B cell lymphomas | 2 (1.9%) | 0 (0%) |
Small lymphocytic lymphoma/leukemia | 2 (1.9%) | 1 (1.1%) |
Nodal marginal zone B cell lymphoma | 1 (0.9%) | 1 (1.1%) |
Lymphoblastic leukemia, T cell | 1 (0.9%) | 0 (0%) |
Unspecified peripheral T cell lymphoma | 1 (0.9%) | 2 (2.1%) |
Angioimmunoblastic T cell lymphoma | 1 (0.9%) | 0 (0%) |
Burkitt’s lymphoma | 1 (0.9%) | 0 (0%) |
B lymphocytic lymphoma/leukemia | 1 (0.9%) | 3 (3.2%) |
Plasma cell differentiation large B cell lymphoma | 1 (0.9%) | 0 (0%) |
B cell lymphoma of mucosa-associated lymphoid tissue | 0 (0%) | 5 (5.3%) |
T-lymphoblastic lymphoma | 0 (0%) | 2 (2.1%) |
NK/T cell lymphoma | 0 (0%) | 1 (1.1%) |
HL | 2 (1.8%) | 1 (1.1%) |
Hodgkin lymphoma nodular sclerosing type | 2 (100%) | 0 (0%) |
Hodgkin lymphoma mixed cellularity type | 0 (0%) | 1 (100%) |